nodes	percent_of_prediction	percent_of_DWPC	metapath
Ponatinib—ABCB1—ulcerative colitis	0.166	1	CbGaD
Ponatinib—ABCB11—Dexamethasone—ulcerative colitis	0.0358	0.0878	CbGbCtD
Ponatinib—ABCG2—Sulfasalazine—ulcerative colitis	0.0341	0.0837	CbGbCtD
Ponatinib—ABCG2—Hydrocortisone—ulcerative colitis	0.0273	0.0671	CbGbCtD
Ponatinib—CYP2C8—Nicotine—ulcerative colitis	0.0233	0.0573	CbGbCtD
Ponatinib—CYP3A4—Budesonide—ulcerative colitis	0.0217	0.0534	CbGbCtD
Ponatinib—CYP2C8—Cholecalciferol—ulcerative colitis	0.0209	0.0514	CbGbCtD
Ponatinib—CYP3A5—Sulfasalazine—ulcerative colitis	0.0189	0.0463	CbGbCtD
Ponatinib—RET—enteric nervous system—ulcerative colitis	0.0188	0.183	CbGeAlD
Ponatinib—ABCG2—Dexamethasone—ulcerative colitis	0.017	0.0417	CbGbCtD
Ponatinib—ABCB1—Methylprednisolone—ulcerative colitis	0.0162	0.0398	CbGbCtD
Ponatinib—CYP3A5—Hydrocortisone—ulcerative colitis	0.0151	0.0372	CbGbCtD
Ponatinib—CYP2D6—Nicotine—ulcerative colitis	0.0149	0.0365	CbGbCtD
Ponatinib—CYP2C8—Hydrocortisone—ulcerative colitis	0.0146	0.0358	CbGbCtD
Ponatinib—CYP2D6—Cholecalciferol—ulcerative colitis	0.0133	0.0328	CbGbCtD
Ponatinib—ABCB11—bile duct—ulcerative colitis	0.0126	0.122	CbGeAlD
Ponatinib—ABCB1—Betamethasone—ulcerative colitis	0.0105	0.0259	CbGbCtD
Ponatinib—ABCB1—Prednisolone—ulcerative colitis	0.0104	0.0255	CbGbCtD
Ponatinib—ABCB1—Hydrocortisone—ulcerative colitis	0.00986	0.0242	CbGbCtD
Ponatinib—ABCB1—Prednisone—ulcerative colitis	0.00982	0.0241	CbGbCtD
Ponatinib—CYP3A4—Methylprednisolone—ulcerative colitis	0.00971	0.0238	CbGbCtD
Ponatinib—ABCB11—bile—ulcerative colitis	0.00965	0.0939	CbGeAlD
Ponatinib—CYP3A4—Nicotine—ulcerative colitis	0.00946	0.0232	CbGbCtD
Ponatinib—CYP3A5—Dexamethasone—ulcerative colitis	0.00942	0.0231	CbGbCtD
Ponatinib—KIT—myenteric nerve plexus—ulcerative colitis	0.0094	0.0915	CbGeAlD
Ponatinib—CYP2C8—Dexamethasone—ulcerative colitis	0.00906	0.0222	CbGbCtD
Ponatinib—CYP3A4—Cholecalciferol—ulcerative colitis	0.00849	0.0208	CbGbCtD
Ponatinib—CYP3A4—Triamcinolone—ulcerative colitis	0.00736	0.0181	CbGbCtD
Ponatinib—CYP3A4—Betamethasone—ulcerative colitis	0.00631	0.0155	CbGbCtD
Ponatinib—CYP3A4—Prednisolone—ulcerative colitis	0.00623	0.0153	CbGbCtD
Ponatinib—ABCB1—Dexamethasone—ulcerative colitis	0.00613	0.0151	CbGbCtD
Ponatinib—CYP3A4—Hydrocortisone—ulcerative colitis	0.00591	0.0145	CbGbCtD
Ponatinib—CYP3A4—Prednisone—ulcerative colitis	0.00588	0.0144	CbGbCtD
Ponatinib—CYP2D6—Dexamethasone—ulcerative colitis	0.00578	0.0142	CbGbCtD
Ponatinib—CYP3A4—Dexamethasone—ulcerative colitis	0.00367	0.00902	CbGbCtD
Ponatinib—FGFR4—digestive system—ulcerative colitis	0.00229	0.0223	CbGeAlD
Ponatinib—FGFR3—epithelium—ulcerative colitis	0.00206	0.02	CbGeAlD
Ponatinib—FGFR4—liver—ulcerative colitis	0.00171	0.0166	CbGeAlD
Ponatinib—LYN—lymphoid tissue—ulcerative colitis	0.00159	0.0155	CbGeAlD
Ponatinib—RET—epithelium—ulcerative colitis	0.00142	0.0138	CbGeAlD
Ponatinib—BCR—lymphoid tissue—ulcerative colitis	0.00137	0.0134	CbGeAlD
Ponatinib—FLT3—lymphoid tissue—ulcerative colitis	0.00136	0.0133	CbGeAlD
Ponatinib—FGFR2—epithelium—ulcerative colitis	0.00135	0.0131	CbGeAlD
Ponatinib—FGFR2—smooth muscle tissue—ulcerative colitis	0.0013	0.0126	CbGeAlD
Ponatinib—TEK—epithelium—ulcerative colitis	0.00129	0.0126	CbGeAlD
Ponatinib—TEK—smooth muscle tissue—ulcerative colitis	0.00124	0.0121	CbGeAlD
Ponatinib—LYN—liver—ulcerative colitis	0.00117	0.0114	CbGeAlD
Ponatinib—FGFR3—liver—ulcerative colitis	0.00117	0.0114	CbGeAlD
Ponatinib—SRC—epithelium—ulcerative colitis	0.00115	0.0112	CbGeAlD
Ponatinib—PDGFRA—smooth muscle tissue—ulcerative colitis	0.00113	0.011	CbGeAlD
Ponatinib—SRC—smooth muscle tissue—ulcerative colitis	0.00111	0.0108	CbGeAlD
Ponatinib—RET—lymphoid tissue—ulcerative colitis	0.00109	0.0106	CbGeAlD
Ponatinib—RET—digestive system—ulcerative colitis	0.00108	0.0105	CbGeAlD
Ponatinib—KDR—epithelium—ulcerative colitis	0.00106	0.0103	CbGeAlD
Ponatinib—ABCB11—digestive system—ulcerative colitis	0.00105	0.0103	CbGeAlD
Ponatinib—FGFR2—digestive system—ulcerative colitis	0.00103	0.00998	CbGeAlD
Ponatinib—KDR—smooth muscle tissue—ulcerative colitis	0.00102	0.0099	CbGeAlD
Ponatinib—BCR—liver—ulcerative colitis	0.00101	0.00983	CbGeAlD
Ponatinib—FLT3—liver—ulcerative colitis	0.001	0.00976	CbGeAlD
Ponatinib—TEK—lymphoid tissue—ulcerative colitis	0.000995	0.00968	CbGeAlD
Ponatinib—KIT—epithelium—ulcerative colitis	0.000936	0.00911	CbGeAlD
Ponatinib—Imatinib—PTGS1—ulcerative colitis	0.000923	0.388	CrCbGaD
Ponatinib—KIT—smooth muscle tissue—ulcerative colitis	0.000901	0.00877	CbGeAlD
Ponatinib—PDGFRA—lymphoid tissue—ulcerative colitis	0.000901	0.00877	CbGeAlD
Ponatinib—FGFR1—liver—ulcerative colitis	0.000898	0.00874	CbGeAlD
Ponatinib—PDGFRA—digestive system—ulcerative colitis	0.00089	0.00867	CbGeAlD
Ponatinib—SRC—lymphoid tissue—ulcerative colitis	0.000884	0.0086	CbGeAlD
Ponatinib—SRC—digestive system—ulcerative colitis	0.000873	0.0085	CbGeAlD
Ponatinib—KDR—lymphoid tissue—ulcerative colitis	0.000813	0.00791	CbGeAlD
Ponatinib—LCK—liver—ulcerative colitis	0.000804	0.00782	CbGeAlD
Ponatinib—KDR—digestive system—ulcerative colitis	0.000803	0.00782	CbGeAlD
Ponatinib—ABCB11—liver—ulcerative colitis	0.000785	0.00764	CbGeAlD
Ponatinib—ABL1—smooth muscle tissue—ulcerative colitis	0.000785	0.00764	CbGeAlD
Ponatinib—FGFR2—liver—ulcerative colitis	0.000764	0.00743	CbGeAlD
Ponatinib—TEK—liver—ulcerative colitis	0.000732	0.00713	CbGeAlD
Ponatinib—KIT—lymphoid tissue—ulcerative colitis	0.000721	0.00701	CbGeAlD
Ponatinib—KIT—digestive system—ulcerative colitis	0.000712	0.00693	CbGeAlD
Ponatinib—PDGFRA—liver—ulcerative colitis	0.000663	0.00646	CbGeAlD
Ponatinib—SRC—liver—ulcerative colitis	0.00065	0.00633	CbGeAlD
Ponatinib—ABL1—lymphoid tissue—ulcerative colitis	0.000627	0.00611	CbGeAlD
Ponatinib—ABL1—digestive system—ulcerative colitis	0.00062	0.00603	CbGeAlD
Ponatinib—KDR—liver—ulcerative colitis	0.000598	0.00582	CbGeAlD
Ponatinib—Nilotinib—ABCB1—ulcerative colitis	0.000538	0.226	CrCbGaD
Ponatinib—KIT—liver—ulcerative colitis	0.00053	0.00516	CbGeAlD
Ponatinib—Imatinib—ALB—ulcerative colitis	0.00047	0.198	CrCbGaD
Ponatinib—ABL1—liver—ulcerative colitis	0.000462	0.00449	CbGeAlD
Ponatinib—Imatinib—ABCB1—ulcerative colitis	0.000449	0.189	CrCbGaD
Ponatinib—CYP3A5—digestive system—ulcerative colitis	0.000363	0.00353	CbGeAlD
Ponatinib—CYP2C8—liver—ulcerative colitis	0.000299	0.00291	CbGeAlD
Ponatinib—ABCG2—liver—ulcerative colitis	0.000291	0.00283	CbGeAlD
Ponatinib—CYP3A4—digestive system—ulcerative colitis	0.000272	0.00265	CbGeAlD
Ponatinib—CYP3A5—liver—ulcerative colitis	0.00027	0.00263	CbGeAlD
Ponatinib—CYP2D6—digestive system—ulcerative colitis	0.000268	0.00261	CbGeAlD
Ponatinib—ABCB1—epithelium—ulcerative colitis	0.000253	0.00247	CbGeAlD
Ponatinib—CYP3A4—liver—ulcerative colitis	0.000203	0.00197	CbGeAlD
Ponatinib—CYP2D6—liver—ulcerative colitis	0.0002	0.00194	CbGeAlD
Ponatinib—ABCB1—lymphoid tissue—ulcerative colitis	0.000195	0.0019	CbGeAlD
Ponatinib—ABCB1—digestive system—ulcerative colitis	0.000193	0.00188	CbGeAlD
Ponatinib—ABCB1—liver—ulcerative colitis	0.000144	0.0014	CbGeAlD
Ponatinib—Malnutrition—Hydrocortisone—ulcerative colitis	0.000138	0.000933	CcSEcCtD
Ponatinib—Erythema—Hydrocortisone—ulcerative colitis	0.000138	0.000933	CcSEcCtD
Ponatinib—Neutropenia—Prednisone—ulcerative colitis	0.000138	0.000932	CcSEcCtD
Ponatinib—Pruritus—Budesonide—ulcerative colitis	0.000138	0.000932	CcSEcCtD
Ponatinib—Decreased appetite—Mesalazine—ulcerative colitis	0.000137	0.000931	CcSEcCtD
Ponatinib—Body temperature increased—Azathioprine—ulcerative colitis	0.000137	0.000929	CcSEcCtD
Ponatinib—Abdominal pain—Azathioprine—ulcerative colitis	0.000137	0.000929	CcSEcCtD
Ponatinib—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.000137	0.000924	CcSEcCtD
Ponatinib—Fatigue—Mesalazine—ulcerative colitis	0.000136	0.000923	CcSEcCtD
Ponatinib—Haemoglobin—Dexamethasone—ulcerative colitis	0.000136	0.00092	CcSEcCtD
Ponatinib—Haemoglobin—Betamethasone—ulcerative colitis	0.000136	0.00092	CcSEcCtD
Ponatinib—Erectile dysfunction—Prednisone—ulcerative colitis	0.000136	0.000918	CcSEcCtD
Ponatinib—Pain—Mesalazine—ulcerative colitis	0.000135	0.000916	CcSEcCtD
Ponatinib—Constipation—Mesalazine—ulcerative colitis	0.000135	0.000916	CcSEcCtD
Ponatinib—Haemorrhage—Betamethasone—ulcerative colitis	0.000135	0.000916	CcSEcCtD
Ponatinib—Haemorrhage—Dexamethasone—ulcerative colitis	0.000135	0.000916	CcSEcCtD
Ponatinib—Angiopathy—Methylprednisolone—ulcerative colitis	0.000135	0.000914	CcSEcCtD
Ponatinib—Mediastinal disorder—Methylprednisolone—ulcerative colitis	0.000134	0.000908	CcSEcCtD
Ponatinib—Arrhythmia—Triamcinolone—ulcerative colitis	0.000133	0.000902	CcSEcCtD
Ponatinib—Weight decreased—Prednisone—ulcerative colitis	0.000133	0.000901	CcSEcCtD
Ponatinib—Diarrhoea—Budesonide—ulcerative colitis	0.000133	0.000901	CcSEcCtD
Ponatinib—Vision blurred—Prednisolone—ulcerative colitis	0.000133	0.0009	CcSEcCtD
Ponatinib—Arrhythmia—Methylprednisolone—ulcerative colitis	0.000133	0.0009	CcSEcCtD
Ponatinib—Hyperglycaemia—Prednisone—ulcerative colitis	0.000133	0.000899	CcSEcCtD
Ponatinib—Visual impairment—Betamethasone—ulcerative colitis	0.00013	0.000882	CcSEcCtD
Ponatinib—Visual impairment—Dexamethasone—ulcerative colitis	0.00013	0.000882	CcSEcCtD
Ponatinib—Mental disorder—Methylprednisolone—ulcerative colitis	0.00013	0.000882	CcSEcCtD
Ponatinib—Erythema—Triamcinolone—ulcerative colitis	0.00013	0.000879	CcSEcCtD
Ponatinib—Erythema—Methylprednisolone—ulcerative colitis	0.000129	0.000877	CcSEcCtD
Ponatinib—Malnutrition—Methylprednisolone—ulcerative colitis	0.000129	0.000877	CcSEcCtD
Ponatinib—Acute coronary syndrome—Prednisone—ulcerative colitis	0.000129	0.000876	CcSEcCtD
Ponatinib—Gastrointestinal pain—Mesalazine—ulcerative colitis	0.000129	0.000876	CcSEcCtD
Ponatinib—Neuropathy peripheral—Prednisone—ulcerative colitis	0.000129	0.000871	CcSEcCtD
Ponatinib—Myocardial infarction—Prednisone—ulcerative colitis	0.000129	0.000871	CcSEcCtD
Ponatinib—Dizziness—Budesonide—ulcerative colitis	0.000129	0.000871	CcSEcCtD
Ponatinib—Eye disorder—Dexamethasone—ulcerative colitis	0.000126	0.000856	CcSEcCtD
Ponatinib—Eye disorder—Betamethasone—ulcerative colitis	0.000126	0.000856	CcSEcCtD
Ponatinib—Back pain—Triamcinolone—ulcerative colitis	0.000125	0.00085	CcSEcCtD
Ponatinib—Body temperature increased—Mesalazine—ulcerative colitis	0.000125	0.000847	CcSEcCtD
Ponatinib—Abdominal pain—Mesalazine—ulcerative colitis	0.000125	0.000847	CcSEcCtD
Ponatinib—Vomiting—Budesonide—ulcerative colitis	0.000124	0.000837	CcSEcCtD
Ponatinib—Angiopathy—Dexamethasone—ulcerative colitis	0.000123	0.000831	CcSEcCtD
Ponatinib—Angiopathy—Betamethasone—ulcerative colitis	0.000123	0.000831	CcSEcCtD
Ponatinib—Rash—Budesonide—ulcerative colitis	0.000123	0.00083	CcSEcCtD
Ponatinib—Dermatitis—Budesonide—ulcerative colitis	0.000122	0.000829	CcSEcCtD
Ponatinib—Headache—Budesonide—ulcerative colitis	0.000122	0.000825	CcSEcCtD
Ponatinib—Hypertension—Prednisolone—ulcerative colitis	0.000122	0.000825	CcSEcCtD
Ponatinib—Arrhythmia—Betamethasone—ulcerative colitis	0.000121	0.000818	CcSEcCtD
Ponatinib—Arrhythmia—Dexamethasone—ulcerative colitis	0.000121	0.000818	CcSEcCtD
Ponatinib—Alopecia—Dexamethasone—ulcerative colitis	0.000119	0.000809	CcSEcCtD
Ponatinib—Alopecia—Betamethasone—ulcerative colitis	0.000119	0.000809	CcSEcCtD
Ponatinib—Hypertension—Hydrocortisone—ulcerative colitis	0.000119	0.000806	CcSEcCtD
Ponatinib—Diarrhoea—Azathioprine—ulcerative colitis	0.000119	0.000804	CcSEcCtD
Ponatinib—Haemoglobin—Prednisone—ulcerative colitis	0.000118	0.000802	CcSEcCtD
Ponatinib—Haemorrhage—Prednisone—ulcerative colitis	0.000118	0.000797	CcSEcCtD
Ponatinib—Erythema—Dexamethasone—ulcerative colitis	0.000118	0.000797	CcSEcCtD
Ponatinib—Erythema—Betamethasone—ulcerative colitis	0.000118	0.000797	CcSEcCtD
Ponatinib—Myalgia—Hydrocortisone—ulcerative colitis	0.000117	0.000794	CcSEcCtD
Ponatinib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.000116	0.000789	CcSEcCtD
Ponatinib—Connective tissue disorder—Prednisone—ulcerative colitis	0.000116	0.000784	CcSEcCtD
Ponatinib—Nausea—Budesonide—ulcerative colitis	0.000115	0.000782	CcSEcCtD
Ponatinib—Oedema—Prednisolone—ulcerative colitis	0.000115	0.00078	CcSEcCtD
Ponatinib—Dizziness—Azathioprine—ulcerative colitis	0.000115	0.000777	CcSEcCtD
Ponatinib—Asthenia—Mesalazine—ulcerative colitis	0.000113	0.000768	CcSEcCtD
Ponatinib—Cough—Triamcinolone—ulcerative colitis	0.000113	0.000767	CcSEcCtD
Ponatinib—Oedema—Hydrocortisone—ulcerative colitis	0.000112	0.000761	CcSEcCtD
Ponatinib—Hypertension—Triamcinolone—ulcerative colitis	0.000112	0.000758	CcSEcCtD
Ponatinib—Pruritus—Mesalazine—ulcerative colitis	0.000112	0.000758	CcSEcCtD
Ponatinib—Hypertension—Methylprednisolone—ulcerative colitis	0.000112	0.000757	CcSEcCtD
Ponatinib—Infection—Hydrocortisone—ulcerative colitis	0.000112	0.000756	CcSEcCtD
Ponatinib—Hyperhidrosis—Prednisolone—ulcerative colitis	0.000111	0.000754	CcSEcCtD
Ponatinib—Myalgia—Triamcinolone—ulcerative colitis	0.00011	0.000748	CcSEcCtD
Ponatinib—Vomiting—Azathioprine—ulcerative colitis	0.00011	0.000747	CcSEcCtD
Ponatinib—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.00011	0.000747	CcSEcCtD
Ponatinib—Myalgia—Methylprednisolone—ulcerative colitis	0.00011	0.000746	CcSEcCtD
Ponatinib—Arthralgia—Methylprednisolone—ulcerative colitis	0.00011	0.000746	CcSEcCtD
Ponatinib—Eye disorder—Prednisone—ulcerative colitis	0.00011	0.000745	CcSEcCtD
Ponatinib—Rash—Azathioprine—ulcerative colitis	0.000109	0.000741	CcSEcCtD
Ponatinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000109	0.000741	CcSEcCtD
Ponatinib—Dermatitis—Azathioprine—ulcerative colitis	0.000109	0.000741	CcSEcCtD
Ponatinib—Flushing—Prednisone—ulcerative colitis	0.000109	0.00074	CcSEcCtD
Ponatinib—Skin disorder—Hydrocortisone—ulcerative colitis	0.000109	0.00074	CcSEcCtD
Ponatinib—Headache—Azathioprine—ulcerative colitis	0.000109	0.000736	CcSEcCtD
Ponatinib—Hyperhidrosis—Hydrocortisone—ulcerative colitis	0.000109	0.000736	CcSEcCtD
Ponatinib—Diarrhoea—Mesalazine—ulcerative colitis	0.000108	0.000733	CcSEcCtD
Ponatinib—Dry mouth—Triamcinolone—ulcerative colitis	0.000108	0.000731	CcSEcCtD
Ponatinib—Angiopathy—Prednisone—ulcerative colitis	0.000107	0.000724	CcSEcCtD
Ponatinib—Oedema—Triamcinolone—ulcerative colitis	0.000106	0.000717	CcSEcCtD
Ponatinib—Arrhythmia—Prednisone—ulcerative colitis	0.000105	0.000712	CcSEcCtD
Ponatinib—Infection—Triamcinolone—ulcerative colitis	0.000105	0.000712	CcSEcCtD
Ponatinib—Infection—Methylprednisolone—ulcerative colitis	0.000105	0.000711	CcSEcCtD
Ponatinib—Dizziness—Mesalazine—ulcerative colitis	0.000105	0.000708	CcSEcCtD
Ponatinib—Insomnia—Prednisolone—ulcerative colitis	0.000104	0.000705	CcSEcCtD
Ponatinib—Alopecia—Prednisone—ulcerative colitis	0.000104	0.000705	CcSEcCtD
Ponatinib—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.000104	0.000702	CcSEcCtD
Ponatinib—Paraesthesia—Prednisolone—ulcerative colitis	0.000103	0.0007	CcSEcCtD
Ponatinib—Mental disorder—Prednisone—ulcerative colitis	0.000103	0.000699	CcSEcCtD
Ponatinib—Nausea—Azathioprine—ulcerative colitis	0.000103	0.000698	CcSEcCtD
Ponatinib—Skin disorder—Methylprednisolone—ulcerative colitis	0.000103	0.000695	CcSEcCtD
Ponatinib—Erythema—Prednisone—ulcerative colitis	0.000103	0.000694	CcSEcCtD
Ponatinib—Malnutrition—Prednisone—ulcerative colitis	0.000103	0.000694	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	0.000102	0.000694	CcSEcCtD
Ponatinib—Hyperhidrosis—Triamcinolone—ulcerative colitis	0.000102	0.000693	CcSEcCtD
Ponatinib—Hyperhidrosis—Methylprednisolone—ulcerative colitis	0.000102	0.000692	CcSEcCtD
Ponatinib—Insomnia—Hydrocortisone—ulcerative colitis	0.000102	0.000689	CcSEcCtD
Ponatinib—Hypertension—Betamethasone—ulcerative colitis	0.000102	0.000688	CcSEcCtD
Ponatinib—Hypertension—Dexamethasone—ulcerative colitis	0.000102	0.000688	CcSEcCtD
Ponatinib—Paraesthesia—Hydrocortisone—ulcerative colitis	0.000101	0.000684	CcSEcCtD
Ponatinib—Vomiting—Mesalazine—ulcerative colitis	0.000101	0.000681	CcSEcCtD
Ponatinib—Myalgia—Dexamethasone—ulcerative colitis	0.0001	0.000679	CcSEcCtD
Ponatinib—Myalgia—Betamethasone—ulcerative colitis	0.0001	0.000679	CcSEcCtD
Ponatinib—Rash—Mesalazine—ulcerative colitis	9.97e-05	0.000675	CcSEcCtD
Ponatinib—Dermatitis—Mesalazine—ulcerative colitis	9.96e-05	0.000675	CcSEcCtD
Ponatinib—Headache—Mesalazine—ulcerative colitis	9.91e-05	0.000671	CcSEcCtD
Ponatinib—Dyspepsia—Hydrocortisone—ulcerative colitis	9.9e-05	0.00067	CcSEcCtD
Ponatinib—Pain—Prednisolone—ulcerative colitis	9.85e-05	0.000667	CcSEcCtD
Ponatinib—Decreased appetite—Hydrocortisone—ulcerative colitis	9.77e-05	0.000662	CcSEcCtD
Ponatinib—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	9.71e-05	0.000657	CcSEcCtD
Ponatinib—Fatigue—Hydrocortisone—ulcerative colitis	9.69e-05	0.000656	CcSEcCtD
Ponatinib—Vision blurred—Prednisone—ulcerative colitis	9.66e-05	0.000654	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	9.65e-05	0.000653	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	9.63e-05	0.000652	CcSEcCtD
Ponatinib—Pain—Hydrocortisone—ulcerative colitis	9.62e-05	0.000651	CcSEcCtD
Ponatinib—Oedema—Betamethasone—ulcerative colitis	9.61e-05	0.000651	CcSEcCtD
Ponatinib—Oedema—Dexamethasone—ulcerative colitis	9.61e-05	0.000651	CcSEcCtD
Ponatinib—Insomnia—Triamcinolone—ulcerative colitis	9.58e-05	0.000648	CcSEcCtD
Ponatinib—Insomnia—Methylprednisolone—ulcerative colitis	9.56e-05	0.000647	CcSEcCtD
Ponatinib—Infection—Betamethasone—ulcerative colitis	9.54e-05	0.000646	CcSEcCtD
Ponatinib—Infection—Dexamethasone—ulcerative colitis	9.54e-05	0.000646	CcSEcCtD
Ponatinib—Paraesthesia—Triamcinolone—ulcerative colitis	9.51e-05	0.000644	CcSEcCtD
Ponatinib—Paraesthesia—Methylprednisolone—ulcerative colitis	9.49e-05	0.000642	CcSEcCtD
Ponatinib—Anaemia—Prednisone—ulcerative colitis	9.48e-05	0.000642	CcSEcCtD
Ponatinib—Dyspnoea—Triamcinolone—ulcerative colitis	9.44e-05	0.000639	CcSEcCtD
Ponatinib—Nervous system disorder—Dexamethasone—ulcerative colitis	9.42e-05	0.000638	CcSEcCtD
Ponatinib—Nervous system disorder—Betamethasone—ulcerative colitis	9.42e-05	0.000638	CcSEcCtD
Ponatinib—Thrombocytopenia—Dexamethasone—ulcerative colitis	9.41e-05	0.000637	CcSEcCtD
Ponatinib—Thrombocytopenia—Betamethasone—ulcerative colitis	9.41e-05	0.000637	CcSEcCtD
Ponatinib—Nausea—Mesalazine—ulcerative colitis	9.39e-05	0.000636	CcSEcCtD
Ponatinib—Dyspepsia—Triamcinolone—ulcerative colitis	9.32e-05	0.000631	CcSEcCtD
Ponatinib—Dyspepsia—Methylprednisolone—ulcerative colitis	9.3e-05	0.00063	CcSEcCtD
Ponatinib—Hyperhidrosis—Dexamethasone—ulcerative colitis	9.29e-05	0.000629	CcSEcCtD
Ponatinib—Hyperhidrosis—Betamethasone—ulcerative colitis	9.29e-05	0.000629	CcSEcCtD
Ponatinib—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	9.2e-05	0.000623	CcSEcCtD
Ponatinib—Fatigue—Triamcinolone—ulcerative colitis	9.13e-05	0.000618	CcSEcCtD
Ponatinib—Fatigue—Methylprednisolone—ulcerative colitis	9.11e-05	0.000617	CcSEcCtD
Ponatinib—Pain—Triamcinolone—ulcerative colitis	9.05e-05	0.000613	CcSEcCtD
Ponatinib—Abdominal pain—Hydrocortisone—ulcerative colitis	8.89e-05	0.000602	CcSEcCtD
Ponatinib—Body temperature increased—Hydrocortisone—ulcerative colitis	8.89e-05	0.000602	CcSEcCtD
Ponatinib—Hypertension—Prednisone—ulcerative colitis	8.85e-05	0.000599	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	8.75e-05	0.000593	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	8.75e-05	0.000593	CcSEcCtD
Ponatinib—Myalgia—Prednisone—ulcerative colitis	8.73e-05	0.000591	CcSEcCtD
Ponatinib—Arthralgia—Prednisone—ulcerative colitis	8.73e-05	0.000591	CcSEcCtD
Ponatinib—Insomnia—Betamethasone—ulcerative colitis	8.69e-05	0.000588	CcSEcCtD
Ponatinib—Insomnia—Dexamethasone—ulcerative colitis	8.69e-05	0.000588	CcSEcCtD
Ponatinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	8.67e-05	0.000587	CcSEcCtD
Ponatinib—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	8.64e-05	0.000585	CcSEcCtD
Ponatinib—Paraesthesia—Betamethasone—ulcerative colitis	8.63e-05	0.000584	CcSEcCtD
Ponatinib—Paraesthesia—Dexamethasone—ulcerative colitis	8.63e-05	0.000584	CcSEcCtD
Ponatinib—Dyspepsia—Betamethasone—ulcerative colitis	8.46e-05	0.000573	CcSEcCtD
Ponatinib—Dyspepsia—Dexamethasone—ulcerative colitis	8.46e-05	0.000573	CcSEcCtD
Ponatinib—Body temperature increased—Triamcinolone—ulcerative colitis	8.37e-05	0.000567	CcSEcCtD
Ponatinib—Oedema—Prednisone—ulcerative colitis	8.37e-05	0.000567	CcSEcCtD
Ponatinib—Abdominal pain—Methylprednisolone—ulcerative colitis	8.35e-05	0.000566	CcSEcCtD
Ponatinib—Decreased appetite—Dexamethasone—ulcerative colitis	8.35e-05	0.000566	CcSEcCtD
Ponatinib—Decreased appetite—Betamethasone—ulcerative colitis	8.35e-05	0.000566	CcSEcCtD
Ponatinib—Infection—Prednisone—ulcerative colitis	8.31e-05	0.000563	CcSEcCtD
Ponatinib—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	8.29e-05	0.000562	CcSEcCtD
Ponatinib—Gastrointestinal disorder—Betamethasone—ulcerative colitis	8.29e-05	0.000562	CcSEcCtD
Ponatinib—Fatigue—Dexamethasone—ulcerative colitis	8.28e-05	0.000561	CcSEcCtD
Ponatinib—Fatigue—Betamethasone—ulcerative colitis	8.28e-05	0.000561	CcSEcCtD
Ponatinib—Pain—Betamethasone—ulcerative colitis	8.22e-05	0.000556	CcSEcCtD
Ponatinib—Pain—Dexamethasone—ulcerative colitis	8.22e-05	0.000556	CcSEcCtD
Ponatinib—Nervous system disorder—Prednisone—ulcerative colitis	8.2e-05	0.000556	CcSEcCtD
Ponatinib—Skin disorder—Prednisone—ulcerative colitis	8.13e-05	0.00055	CcSEcCtD
Ponatinib—Hyperhidrosis—Prednisone—ulcerative colitis	8.09e-05	0.000548	CcSEcCtD
Ponatinib—Asthenia—Hydrocortisone—ulcerative colitis	8.07e-05	0.000546	CcSEcCtD
Ponatinib—Pruritus—Hydrocortisone—ulcerative colitis	7.96e-05	0.000539	CcSEcCtD
Ponatinib—Gastrointestinal pain—Dexamethasone—ulcerative colitis	7.86e-05	0.000532	CcSEcCtD
Ponatinib—Gastrointestinal pain—Betamethasone—ulcerative colitis	7.86e-05	0.000532	CcSEcCtD
Ponatinib—Diarrhoea—Hydrocortisone—ulcerative colitis	7.69e-05	0.000521	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Prednisone—ulcerative colitis	7.62e-05	0.000516	CcSEcCtD
Ponatinib—Dizziness—Prednisolone—ulcerative colitis	7.61e-05	0.000516	CcSEcCtD
Ponatinib—Asthenia—Triamcinolone—ulcerative colitis	7.6e-05	0.000514	CcSEcCtD
Ponatinib—Abdominal pain—Betamethasone—ulcerative colitis	7.59e-05	0.000514	CcSEcCtD
Ponatinib—Body temperature increased—Dexamethasone—ulcerative colitis	7.59e-05	0.000514	CcSEcCtD
Ponatinib—Body temperature increased—Betamethasone—ulcerative colitis	7.59e-05	0.000514	CcSEcCtD
Ponatinib—Abdominal pain—Dexamethasone—ulcerative colitis	7.59e-05	0.000514	CcSEcCtD
Ponatinib—Asthenia—Methylprednisolone—ulcerative colitis	7.58e-05	0.000513	CcSEcCtD
Ponatinib—Insomnia—Prednisone—ulcerative colitis	7.57e-05	0.000512	CcSEcCtD
Ponatinib—Paraesthesia—Prednisone—ulcerative colitis	7.51e-05	0.000509	CcSEcCtD
Ponatinib—Pruritus—Triamcinolone—ulcerative colitis	7.49e-05	0.000507	CcSEcCtD
Ponatinib—Pruritus—Methylprednisolone—ulcerative colitis	7.47e-05	0.000506	CcSEcCtD
Ponatinib—Dizziness—Hydrocortisone—ulcerative colitis	7.44e-05	0.000504	CcSEcCtD
Ponatinib—Dyspepsia—Prednisone—ulcerative colitis	7.36e-05	0.000499	CcSEcCtD
Ponatinib—Decreased appetite—Prednisone—ulcerative colitis	7.27e-05	0.000493	CcSEcCtD
Ponatinib—Rash—Prednisolone—ulcerative colitis	7.26e-05	0.000492	CcSEcCtD
Ponatinib—Dermatitis—Prednisolone—ulcerative colitis	7.25e-05	0.000491	CcSEcCtD
Ponatinib—Diarrhoea—Methylprednisolone—ulcerative colitis	7.23e-05	0.000489	CcSEcCtD
Ponatinib—Fatigue—Prednisone—ulcerative colitis	7.21e-05	0.000488	CcSEcCtD
Ponatinib—Headache—Prednisolone—ulcerative colitis	7.21e-05	0.000488	CcSEcCtD
Ponatinib—Constipation—Prednisone—ulcerative colitis	7.15e-05	0.000484	CcSEcCtD
Ponatinib—Vomiting—Hydrocortisone—ulcerative colitis	7.15e-05	0.000484	CcSEcCtD
Ponatinib—Rash—Hydrocortisone—ulcerative colitis	7.09e-05	0.00048	CcSEcCtD
Ponatinib—Dermatitis—Hydrocortisone—ulcerative colitis	7.08e-05	0.00048	CcSEcCtD
Ponatinib—Headache—Hydrocortisone—ulcerative colitis	7.04e-05	0.000477	CcSEcCtD
Ponatinib—Dizziness—Triamcinolone—ulcerative colitis	7e-05	0.000474	CcSEcCtD
Ponatinib—Dizziness—Methylprednisolone—ulcerative colitis	6.99e-05	0.000473	CcSEcCtD
Ponatinib—Asthenia—Betamethasone—ulcerative colitis	6.89e-05	0.000467	CcSEcCtD
Ponatinib—Asthenia—Dexamethasone—ulcerative colitis	6.89e-05	0.000467	CcSEcCtD
Ponatinib—Gastrointestinal pain—Prednisone—ulcerative colitis	6.84e-05	0.000463	CcSEcCtD
Ponatinib—Nausea—Prednisolone—ulcerative colitis	6.84e-05	0.000463	CcSEcCtD
Ponatinib—Pruritus—Betamethasone—ulcerative colitis	6.8e-05	0.00046	CcSEcCtD
Ponatinib—Pruritus—Dexamethasone—ulcerative colitis	6.8e-05	0.00046	CcSEcCtD
Ponatinib—Vomiting—Triamcinolone—ulcerative colitis	6.73e-05	0.000456	CcSEcCtD
Ponatinib—Vomiting—Methylprednisolone—ulcerative colitis	6.72e-05	0.000455	CcSEcCtD
Ponatinib—Nausea—Hydrocortisone—ulcerative colitis	6.68e-05	0.000452	CcSEcCtD
Ponatinib—Rash—Triamcinolone—ulcerative colitis	6.68e-05	0.000452	CcSEcCtD
Ponatinib—Dermatitis—Triamcinolone—ulcerative colitis	6.67e-05	0.000452	CcSEcCtD
Ponatinib—Rash—Methylprednisolone—ulcerative colitis	6.66e-05	0.000451	CcSEcCtD
Ponatinib—Dermatitis—Methylprednisolone—ulcerative colitis	6.65e-05	0.000451	CcSEcCtD
Ponatinib—Headache—Triamcinolone—ulcerative colitis	6.63e-05	0.000449	CcSEcCtD
Ponatinib—Headache—Methylprednisolone—ulcerative colitis	6.62e-05	0.000448	CcSEcCtD
Ponatinib—Abdominal pain—Prednisone—ulcerative colitis	6.61e-05	0.000448	CcSEcCtD
Ponatinib—Body temperature increased—Prednisone—ulcerative colitis	6.61e-05	0.000448	CcSEcCtD
Ponatinib—Diarrhoea—Dexamethasone—ulcerative colitis	6.57e-05	0.000445	CcSEcCtD
Ponatinib—Diarrhoea—Betamethasone—ulcerative colitis	6.57e-05	0.000445	CcSEcCtD
Ponatinib—Dizziness—Dexamethasone—ulcerative colitis	6.35e-05	0.00043	CcSEcCtD
Ponatinib—Dizziness—Betamethasone—ulcerative colitis	6.35e-05	0.00043	CcSEcCtD
Ponatinib—Nausea—Triamcinolone—ulcerative colitis	6.29e-05	0.000426	CcSEcCtD
Ponatinib—Nausea—Methylprednisolone—ulcerative colitis	6.28e-05	0.000425	CcSEcCtD
Ponatinib—Vomiting—Dexamethasone—ulcerative colitis	6.11e-05	0.000414	CcSEcCtD
Ponatinib—Vomiting—Betamethasone—ulcerative colitis	6.11e-05	0.000414	CcSEcCtD
Ponatinib—Rash—Betamethasone—ulcerative colitis	6.06e-05	0.00041	CcSEcCtD
Ponatinib—Rash—Dexamethasone—ulcerative colitis	6.06e-05	0.00041	CcSEcCtD
Ponatinib—Dermatitis—Betamethasone—ulcerative colitis	6.05e-05	0.00041	CcSEcCtD
Ponatinib—Dermatitis—Dexamethasone—ulcerative colitis	6.05e-05	0.00041	CcSEcCtD
Ponatinib—Headache—Dexamethasone—ulcerative colitis	6.02e-05	0.000408	CcSEcCtD
Ponatinib—Headache—Betamethasone—ulcerative colitis	6.02e-05	0.000408	CcSEcCtD
Ponatinib—Asthenia—Prednisone—ulcerative colitis	6e-05	0.000406	CcSEcCtD
Ponatinib—Pruritus—Prednisone—ulcerative colitis	5.92e-05	0.000401	CcSEcCtD
Ponatinib—Diarrhoea—Prednisone—ulcerative colitis	5.72e-05	0.000388	CcSEcCtD
Ponatinib—Nausea—Dexamethasone—ulcerative colitis	5.71e-05	0.000386	CcSEcCtD
Ponatinib—Nausea—Betamethasone—ulcerative colitis	5.71e-05	0.000386	CcSEcCtD
Ponatinib—Dizziness—Prednisone—ulcerative colitis	5.53e-05	0.000375	CcSEcCtD
Ponatinib—Vomiting—Prednisone—ulcerative colitis	5.32e-05	0.00036	CcSEcCtD
Ponatinib—Rash—Prednisone—ulcerative colitis	5.28e-05	0.000357	CcSEcCtD
Ponatinib—Dermatitis—Prednisone—ulcerative colitis	5.27e-05	0.000357	CcSEcCtD
Ponatinib—Headache—Prednisone—ulcerative colitis	5.24e-05	0.000355	CcSEcCtD
Ponatinib—Nausea—Prednisone—ulcerative colitis	4.97e-05	0.000337	CcSEcCtD
Ponatinib—FGFR3—Signaling Pathways—CXCL8—ulcerative colitis	7.83e-06	4.51e-05	CbGpPWpGaD
Ponatinib—KIT—Immune System—IL2—ulcerative colitis	7.82e-06	4.5e-05	CbGpPWpGaD
Ponatinib—KIT—Disease—PTGS2—ulcerative colitis	7.79e-06	4.48e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—DLD—ulcerative colitis	7.77e-06	4.47e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—CALM3—ulcerative colitis	7.76e-06	4.47e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—ADCY5—ulcerative colitis	7.76e-06	4.47e-05	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—STAT3—ulcerative colitis	7.75e-06	4.46e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	7.66e-06	4.41e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—RIPK2—ulcerative colitis	7.65e-06	4.4e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—CRP—ulcerative colitis	7.62e-06	4.39e-05	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—NFKB1—ulcerative colitis	7.62e-06	4.38e-05	CbGpPWpGaD
Ponatinib—SRC—Axon guidance—IL6—ulcerative colitis	7.59e-06	4.36e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—ADRB2—ulcerative colitis	7.5e-06	4.31e-05	CbGpPWpGaD
Ponatinib—FGFR1—Innate Immune System—IL6—ulcerative colitis	7.49e-06	4.31e-05	CbGpPWpGaD
Ponatinib—LYN—Immune System—JAK2—ulcerative colitis	7.48e-06	4.31e-05	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—IL2—ulcerative colitis	7.48e-06	4.31e-05	CbGpPWpGaD
Ponatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	7.48e-06	4.31e-05	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—ALB—ulcerative colitis	7.48e-06	4.3e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—JAK2—ulcerative colitis	7.47e-06	4.3e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Innate Immune System—IL6—ulcerative colitis	7.47e-06	4.3e-05	CbGpPWpGaD
Ponatinib—LYN—Developmental Biology—IL6—ulcerative colitis	7.46e-06	4.29e-05	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—NFKB1—ulcerative colitis	7.45e-06	4.29e-05	CbGpPWpGaD
Ponatinib—ABL1—Immune System—JAK2—ulcerative colitis	7.45e-06	4.29e-05	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—IL1B—ulcerative colitis	7.45e-06	4.29e-05	CbGpPWpGaD
Ponatinib—FGFR1—Disease—CD4—ulcerative colitis	7.45e-06	4.28e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—IL1B—ulcerative colitis	7.43e-06	4.27e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—CD4—ulcerative colitis	7.43e-06	4.27e-05	CbGpPWpGaD
Ponatinib—ABL1—Developmental Biology—IL6—ulcerative colitis	7.42e-06	4.27e-05	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—IL2—ulcerative colitis	7.42e-06	4.27e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—IL2—ulcerative colitis	7.4e-06	4.26e-05	CbGpPWpGaD
Ponatinib—FGFR1—Disease—PTGS2—ulcerative colitis	7.39e-06	4.25e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—PTGS2—ulcerative colitis	7.37e-06	4.24e-05	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—ADCY5—ulcerative colitis	7.37e-06	4.24e-05	CbGpPWpGaD
Ponatinib—LYN—Immune System—IFNG—ulcerative colitis	7.35e-06	4.23e-05	CbGpPWpGaD
Ponatinib—KIT—Immune System—NFKB1—ulcerative colitis	7.32e-06	4.21e-05	CbGpPWpGaD
Ponatinib—SRC—Adaptive Immune System—NFKB1—ulcerative colitis	7.31e-06	4.21e-05	CbGpPWpGaD
Ponatinib—ABL1—Immune System—IFNG—ulcerative colitis	7.31e-06	4.21e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—TLR4—ulcerative colitis	7.31e-06	4.2e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—HLA-DRB1—ulcerative colitis	7.3e-06	4.2e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—CALM3—ulcerative colitis	7.28e-06	4.19e-05	CbGpPWpGaD
Ponatinib—LYN—Immune System—RELA—ulcerative colitis	7.25e-06	4.17e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—RELA—ulcerative colitis	7.24e-06	4.17e-05	CbGpPWpGaD
Ponatinib—ABL1—Immune System—RELA—ulcerative colitis	7.21e-06	4.15e-05	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—TGFB1—ulcerative colitis	7.18e-06	4.13e-05	CbGpPWpGaD
Ponatinib—LYN—Immune System—CD4—ulcerative colitis	7.09e-06	4.08e-05	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—MMP9—ulcerative colitis	7.08e-06	4.08e-05	CbGpPWpGaD
Ponatinib—ABL1—Immune System—CD4—ulcerative colitis	7.06e-06	4.06e-05	CbGpPWpGaD
Ponatinib—SRC—Hemostasis—TGFB1—ulcerative colitis	7.05e-06	4.05e-05	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—NFKB1—ulcerative colitis	7.01e-06	4.03e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—ICAM1—ulcerative colitis	7.01e-06	4.03e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—PTGS1—ulcerative colitis	7e-06	4.03e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—CDH1—ulcerative colitis	7e-06	4.03e-05	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—NFKB1—ulcerative colitis	6.95e-06	4e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—NFKB1—ulcerative colitis	6.93e-06	3.99e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	6.89e-06	3.96e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—CXCL8—ulcerative colitis	6.82e-06	3.93e-05	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—IL6—ulcerative colitis	6.8e-06	3.91e-05	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—TNF—ulcerative colitis	6.71e-06	3.86e-05	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—STAT3—ulcerative colitis	6.7e-06	3.85e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—ADRB2—ulcerative colitis	6.64e-06	3.82e-05	CbGpPWpGaD
Ponatinib—LYN—Innate Immune System—IL6—ulcerative colitis	6.59e-06	3.79e-05	CbGpPWpGaD
Ponatinib—KIT—Immune System—STAT3—ulcerative colitis	6.58e-06	3.79e-05	CbGpPWpGaD
Ponatinib—ABL1—Innate Immune System—IL6—ulcerative colitis	6.56e-06	3.77e-05	CbGpPWpGaD
Ponatinib—LCK—Hemostasis—TP53—ulcerative colitis	6.55e-06	3.77e-05	CbGpPWpGaD
Ponatinib—LYN—Immune System—IL1B—ulcerative colitis	6.55e-06	3.77e-05	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—PTGS2—ulcerative colitis	6.54e-06	3.76e-05	CbGpPWpGaD
Ponatinib—LYN—Immune System—IL2—ulcerative colitis	6.53e-06	3.76e-05	CbGpPWpGaD
Ponatinib—ABL1—Immune System—IL1B—ulcerative colitis	6.52e-06	3.75e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—IL2—ulcerative colitis	6.52e-06	3.75e-05	CbGpPWpGaD
Ponatinib—ABL1—Immune System—IL2—ulcerative colitis	6.5e-06	3.74e-05	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—TP53—ulcerative colitis	6.5e-06	3.74e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—ADCY5—ulcerative colitis	6.36e-06	3.66e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—CALM3—ulcerative colitis	6.31e-06	3.63e-05	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—STAT3—ulcerative colitis	6.3e-06	3.62e-05	CbGpPWpGaD
Ponatinib—FGFR3—Disease—IL6—ulcerative colitis	6.28e-06	3.61e-05	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—STAT3—ulcerative colitis	6.24e-06	3.59e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—STAT3—ulcerative colitis	6.23e-06	3.58e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—CDH1—ulcerative colitis	6.19e-06	3.56e-05	CbGpPWpGaD
Ponatinib—FGFR2—Disease—STAT3—ulcerative colitis	6.18e-06	3.56e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—MMP9—ulcerative colitis	6.17e-06	3.55e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—JAK2—ulcerative colitis	6.13e-06	3.53e-05	CbGpPWpGaD
Ponatinib—LYN—Immune System—NFKB1—ulcerative colitis	6.11e-06	3.52e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—NFKB1—ulcerative colitis	6.1e-06	3.51e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—PTGS1—ulcerative colitis	6.1e-06	3.51e-05	CbGpPWpGaD
Ponatinib—ABL1—Immune System—NFKB1—ulcerative colitis	6.08e-06	3.5e-05	CbGpPWpGaD
Ponatinib—KIT—Disease—STAT3—ulcerative colitis	6.07e-06	3.5e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	6.03e-06	3.47e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—IFNG—ulcerative colitis	6.02e-06	3.46e-05	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—IL6—ulcerative colitis	5.95e-06	3.42e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—RELA—ulcerative colitis	5.94e-06	3.42e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—JAK2—ulcerative colitis	5.9e-06	3.4e-05	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—TGFB1—ulcerative colitis	5.84e-06	3.36e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—CD4—ulcerative colitis	5.82e-06	3.35e-05	CbGpPWpGaD
Ponatinib—SRC—Hemostasis—TP53—ulcerative colitis	5.8e-06	3.34e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—JAK2—ulcerative colitis	5.8e-06	3.33e-05	CbGpPWpGaD
Ponatinib—FGFR1—Disease—STAT3—ulcerative colitis	5.76e-06	3.32e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—STAT3—ulcerative colitis	5.75e-06	3.31e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—PTGS1—ulcerative colitis	5.75e-06	3.31e-05	CbGpPWpGaD
Ponatinib—FGFR2—Disease—TGFB1—ulcerative colitis	5.73e-06	3.3e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—RELA—ulcerative colitis	5.72e-06	3.29e-05	CbGpPWpGaD
Ponatinib—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	5.71e-06	3.28e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—JAK2—ulcerative colitis	5.66e-06	3.26e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—ABCB1—ulcerative colitis	5.66e-06	3.26e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—ADCY5—ulcerative colitis	5.63e-06	3.24e-05	CbGpPWpGaD
Ponatinib—KIT—Disease—TGFB1—ulcerative colitis	5.63e-06	3.24e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—RELA—ulcerative colitis	5.61e-06	3.23e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—JAK2—ulcerative colitis	5.5e-06	3.16e-05	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—PPARG—ulcerative colitis	5.5e-06	3.16e-05	CbGpPWpGaD
Ponatinib—LYN—Immune System—STAT3—ulcerative colitis	5.49e-06	3.16e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—CALM3—ulcerative colitis	5.49e-06	3.16e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—JAK2—ulcerative colitis	5.49e-06	3.16e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—STAT3—ulcerative colitis	5.49e-06	3.16e-05	CbGpPWpGaD
Ponatinib—ABL1—Immune System—STAT3—ulcerative colitis	5.47e-06	3.15e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—JAK2—ulcerative colitis	5.43e-06	3.13e-05	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—IL6—ulcerative colitis	5.41e-06	3.11e-05	CbGpPWpGaD
Ponatinib—LCK—Innate Immune System—IL6—ulcerative colitis	5.4e-06	3.11e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—CXCL8—ulcerative colitis	5.39e-06	3.1e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—IL1B—ulcerative colitis	5.37e-06	3.09e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—CD4—ulcerative colitis	5.37e-06	3.09e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—IL2—ulcerative colitis	5.35e-06	3.08e-05	CbGpPWpGaD
Ponatinib—FGFR1—Disease—TGFB1—ulcerative colitis	5.34e-06	3.08e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—IFNG—ulcerative colitis	5.33e-06	3.07e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—TGFB1—ulcerative colitis	5.33e-06	3.07e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—PTGS2—ulcerative colitis	5.33e-06	3.07e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—RELA—ulcerative colitis	5.33e-06	3.07e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—RELA—ulcerative colitis	5.31e-06	3.06e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—CXCL8—ulcerative colitis	5.29e-06	3.04e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—ADCY5—ulcerative colitis	5.28e-06	3.04e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—RELA—ulcerative colitis	5.26e-06	3.03e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—CALM3—ulcerative colitis	5.18e-06	2.98e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—CD4—ulcerative colitis	5.15e-06	2.96e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—IL2—ulcerative colitis	5.15e-06	2.96e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—TGFB1—ulcerative colitis	5.09e-06	2.93e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—IL2—ulcerative colitis	5.05e-06	2.91e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—CXCL8—ulcerative colitis	5.02e-06	2.89e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—JAK2—ulcerative colitis	5.01e-06	2.89e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—NFKB1—ulcerative colitis	5.01e-06	2.88e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—CXCL8—ulcerative colitis	5.01e-06	2.88e-05	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—ALB—ulcerative colitis	4.94e-06	2.84e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—ABCB1—ulcerative colitis	4.9e-06	2.82e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—MMP9—ulcerative colitis	4.87e-06	2.8e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—JAK2—ulcerative colitis	4.84e-06	2.78e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—NFKB1—ulcerative colitis	4.82e-06	2.77e-05	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—TP53—ulcerative colitis	4.81e-06	2.77e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—IL2—ulcerative colitis	4.8e-06	2.76e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—IL2—ulcerative colitis	4.78e-06	2.75e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—MMP9—ulcerative colitis	4.78e-06	2.75e-05	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—IL6—ulcerative colitis	4.78e-06	2.75e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—IL1B—ulcerative colitis	4.75e-06	2.74e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—CD4—ulcerative colitis	4.75e-06	2.74e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—IL2—ulcerative colitis	4.74e-06	2.73e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—NFKB1—ulcerative colitis	4.73e-06	2.72e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—PTGS2—ulcerative colitis	4.72e-06	2.72e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—RELA—ulcerative colitis	4.69e-06	2.7e-05	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—IL6—ulcerative colitis	4.68e-06	2.69e-05	CbGpPWpGaD
Ponatinib—KIT—Immune System—IL6—ulcerative colitis	4.6e-06	2.64e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—ADCY5—ulcerative colitis	4.57e-06	2.63e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—MMP9—ulcerative colitis	4.54e-06	2.61e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—MMP9—ulcerative colitis	4.53e-06	2.61e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—STAT3—ulcerative colitis	4.5e-06	2.59e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—NFKB1—ulcerative colitis	4.49e-06	2.58e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—NFKB1—ulcerative colitis	4.48e-06	2.58e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—NFKB1—ulcerative colitis	4.44e-06	2.55e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—CXCL8—ulcerative colitis	4.42e-06	2.54e-05	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—IL6—ulcerative colitis	4.4e-06	2.53e-05	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—IL6—ulcerative colitis	4.36e-06	2.51e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—IL6—ulcerative colitis	4.35e-06	2.5e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—STAT3—ulcerative colitis	4.33e-06	2.49e-05	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—PTGS2—ulcerative colitis	4.32e-06	2.49e-05	CbGpPWpGaD
Ponatinib—FGFR2—Disease—IL6—ulcerative colitis	4.32e-06	2.49e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—STAT3—ulcerative colitis	4.25e-06	2.45e-05	CbGpPWpGaD
Ponatinib—KIT—Disease—IL6—ulcerative colitis	4.24e-06	2.44e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—IL2—ulcerative colitis	4.22e-06	2.43e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—TP53—ulcerative colitis	4.19e-06	2.41e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—STAT3—ulcerative colitis	4.16e-06	2.39e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—STAT3—ulcerative colitis	4.04e-06	2.32e-05	CbGpPWpGaD
Ponatinib—FGFR1—Disease—IL6—ulcerative colitis	4.03e-06	2.32e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—STAT3—ulcerative colitis	4.03e-06	2.32e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—ABCB1—ulcerative colitis	4.03e-06	2.32e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—IL6—ulcerative colitis	4.02e-06	2.31e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—TGFB1—ulcerative colitis	4.01e-06	2.31e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—MMP9—ulcerative colitis	3.99e-06	2.3e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—STAT3—ulcerative colitis	3.99e-06	2.29e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—ADCY5—ulcerative colitis	3.98e-06	2.29e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—JAK2—ulcerative colitis	3.97e-06	2.28e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—NFKB1—ulcerative colitis	3.95e-06	2.27e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—TGFB1—ulcerative colitis	3.94e-06	2.27e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—PPARG—ulcerative colitis	3.94e-06	2.27e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—TGFB1—ulcerative colitis	3.85e-06	2.22e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—RELA—ulcerative colitis	3.84e-06	2.21e-05	CbGpPWpGaD
Ponatinib—LYN—Immune System—IL6—ulcerative colitis	3.84e-06	2.21e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—IL6—ulcerative colitis	3.83e-06	2.21e-05	CbGpPWpGaD
Ponatinib—ABL1—Immune System—IL6—ulcerative colitis	3.82e-06	2.2e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PTGS1—ulcerative colitis	3.76e-06	2.16e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—ADCY5—ulcerative colitis	3.76e-06	2.16e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—TGFB1—ulcerative colitis	3.74e-06	2.15e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—TGFB1—ulcerative colitis	3.73e-06	2.15e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—STAT3—ulcerative colitis	3.68e-06	2.12e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—CXCL8—ulcerative colitis	3.62e-06	2.08e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—STAT3—ulcerative colitis	3.55e-06	2.04e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—ALB—ulcerative colitis	3.54e-06	2.04e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—JAK2—ulcerative colitis	3.51e-06	2.02e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—IL2—ulcerative colitis	3.46e-06	1.99e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—TGFB1—ulcerative colitis	3.41e-06	1.96e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—PPARG—ulcerative colitis	3.41e-06	1.96e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—RELA—ulcerative colitis	3.4e-06	1.96e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—CALM3—ulcerative colitis	3.38e-06	1.95e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—TP53—ulcerative colitis	3.31e-06	1.9e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—TGFB1—ulcerative colitis	3.29e-06	1.89e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—MMP9—ulcerative colitis	3.27e-06	1.88e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—TP53—ulcerative colitis	3.25e-06	1.87e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—NFKB1—ulcerative colitis	3.24e-06	1.86e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—CXCL8—ulcerative colitis	3.2e-06	1.84e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—IL6—ulcerative colitis	3.15e-06	1.81e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—PTGS2—ulcerative colitis	3.1e-06	1.78e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—TP53—ulcerative colitis	3.08e-06	1.77e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—TP53—ulcerative colitis	3.07e-06	1.77e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—ALB—ulcerative colitis	3.07e-06	1.77e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—IL2—ulcerative colitis	3.06e-06	1.76e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—IL6—ulcerative colitis	3.03e-06	1.74e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—PPARG—ulcerative colitis	2.97e-06	1.71e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—IL6—ulcerative colitis	2.97e-06	1.71e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—STAT3—ulcerative colitis	2.91e-06	1.68e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—IL6—ulcerative colitis	2.9e-06	1.67e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—MMP9—ulcerative colitis	2.9e-06	1.67e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—NFKB1—ulcerative colitis	2.87e-06	1.65e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—IL6—ulcerative colitis	2.82e-06	1.62e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—IL6—ulcerative colitis	2.81e-06	1.62e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—PPARG—ulcerative colitis	2.8e-06	1.61e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—IL6—ulcerative colitis	2.78e-06	1.6e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—TP53—ulcerative colitis	2.71e-06	1.56e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—TGFB1—ulcerative colitis	2.7e-06	1.55e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—PTGS2—ulcerative colitis	2.68e-06	1.54e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—ALB—ulcerative colitis	2.67e-06	1.54e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—ABCB1—ulcerative colitis	2.63e-06	1.51e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—STAT3—ulcerative colitis	2.58e-06	1.48e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—IL6—ulcerative colitis	2.57e-06	1.48e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—ALB—ulcerative colitis	2.52e-06	1.45e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—IL6—ulcerative colitis	2.48e-06	1.43e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—ADCY5—ulcerative colitis	2.46e-06	1.41e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—TGFB1—ulcerative colitis	2.39e-06	1.37e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—PTGS2—ulcerative colitis	2.34e-06	1.35e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—TP53—ulcerative colitis	2.22e-06	1.28e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—PTGS2—ulcerative colitis	2.2e-06	1.27e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—IL6—ulcerative colitis	2.03e-06	1.17e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—TP53—ulcerative colitis	1.97e-06	1.13e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PPARG—ulcerative colitis	1.83e-06	1.05e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—IL6—ulcerative colitis	1.8e-06	1.04e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—ALB—ulcerative colitis	1.65e-06	9.47e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PTGS2—ulcerative colitis	1.44e-06	8.29e-06	CbGpPWpGaD
